Form 4: iSpecimen Inc. Director Katharyn Field Reports Stock Option Grant

Director Katharyn Field reports the acquisition of stock options in iSpecimen Inc. following a 20-for-1 reverse stock split.

Summary

• Katharyn Field, a director of iSpecimen Inc. (ISPC), filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Field on September 25, 2024.
• These options are for 168 shares of common stock at an exercise price of $5.12.
• The options vest in two tranches: 84 shares on September 30, 2024, and 84 shares on December 31, 2024.
• The grant follows a 20-for-1 reverse stock split that was effective on September 13, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a director, which is a common practice.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule provides an incentive for continued service and contribution to the company.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• The size of the grant and the vesting schedule are typical for director compensation packages, aligning with industry norms for incentivizing long-term value creation.
• Comparable companies in the diagnostics and life sciences tools space, such as Bio-Rad Laboratories or Agilent Technologies, also utilize stock options as part of their executive and director compensation plans.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the director to work towards increasing shareholder value.

Key Dates

Keywords

iSpecimen Inc., Katharyn Field, stock options, Form 4, director, ISPC, reverse stock split, SEC filing